Código QR

Impact of pathologic response and individual prognosis after neoadjuvant treatment in patients with early HER2+ and triple-negative breast cancer

Background: Pathologic complete response (pCR) after neoadjuvant treatment (NAT) is prognostic for recurrence-free survival (RFS) and overall survival (OS) in breast cancer (BC). We assessed prognostic factors for RFS and OS in patients with pCR compared to residual disease (RD) in HER2+ and triple-...

ver descrição completa

Na minha lista:
Principais autores: Chiara Corti, Tianyu Li, Alyssa R. Martin, Melissa E. Hughes, Tonia Parker, Tyzaire S. Duporte, Giuseppe Curigliano, Tari A. King, Elizabeth A. Mittendorf, Nancy U. Lin, Nabihah Tayob, Sara M. Tolaney
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2026-06-01
Colecção:Breast
Assuntos:
Breast cancer
Neoadjuvant
Triple negative
HER2
Pathologic response
Outcomes
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S0960977626000755
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados